Showing 5731-5740 of 5909 results for "".
- ASCRS Releases Preliminary CyPass Withdrawal Consensus Statementhttps://modernod.com/news/ascrs-releases-preliminary-cypass-withdrawal-consensus-statement/2479843/The American Society of Cataract and Refractive Surgery convened a CyPass Withdrawal Task Force to review the data from the COMPASS-XT study and related research and develop an independent physician guidance document associated with the voluntary withdrawal of Alcon’s CyPass Micro-Stent. To
- Bayer, Novartis Lose Case Seeking to End NHS Use of Avastin in Wet AMDhttps://modernod.com/news/bayer-novartis-lose-case-seeking-to-end-nhs-use-of-avastin-in-wet-amd/2479853/The UK High Court on Friday ruled that 12 NHS bodies in the north-east of England can continue to use Roche’s Avastin (bevacizumab) for the treatment of wet age-related macular degeneration (AMD) after dismissing a challenge by Bayer and Novartis. In the case, Bayer and Novartis, which mark
- Heidelberg Engineering Announces CE Mark Approval of Anterionhttps://modernod.com/news/heidelberg-engineering-announces-the-ce-marking-of-anterion/2479854/Heidelberg Engineering announced the CE-marking of Anterion, a platform designed to transform anterior segment diagnostics and workflow. The new Anterion provides anterior segment examinations and measurements in one modular, upgradeable platform. It is a single, workflow-efficient solutio
- MacuLogix Launches the AdaptDx in Europehttps://modernod.com/news/maculogix-launches-the-adaptdx-in-europe-at-euretina/2479856/MacuLogix will launch the AdaptDx in Europe during its debut at the European Society of Retina Specialists (EURETINA) annual congress
- Nidek Launches the GS-1 Gonioscopehttps://modernod.com/news/nidek-launches-the-gs-1-gonioscope/2479862/Nidek has announced the launch of the GS-1 Gonioscope. The GS-1 is the first automated gonioscopy device enabling 360-degree color iridocorneal angle imaging allowing more clinicians to reliably perform gonioscopy in
- IOT Launches New Corporate Brandinghttps://modernod.com/news/iot-launches-new-corporate-branding/2479870/Optical technology company IOT has announced a change in brand identity as part of an overall strategy to better communicate its culture, values, and approach to market. The new website and social media profiles are designed to help the company share optical knowledge as well as information abou
- Allergan Announces New Partnership With the International Diabetes Federationhttps://modernod.com/news/allergan-announces-new-partnership-with-the-international-diabetes-federation/2479873/Allergan has announced a collaborative partnership with the International Diabetes Federation (IDF) with the aim of developing a global approach to screen, diagnose, and manage diabetic macular edema (DME). Diabetic eye health is a key concern for IDF and Allergan. The partnership will bri
- Neurolens Appoints Thomas J. Chirillo as Chief Commercial Officerhttps://modernod.com/news/neurolens-appoints-thomas-j-chirillo-as-chief-commercial-officer/2479876/Neurolens announced the appointment of Thomas J. Chirillo as Chief Commercial Officer. An accomplished senior healthcare executive with deep experience in the eye care space, Mr. Chirillo brings almost 4 decades of sales and marketing experience to neurolens. “We’re thrilled to have someon
- FDA Grants Lin BioScience Rare Pediatric Disease Status for LBS-008 to Treat Stargardt Diseasehttps://modernod.com/news/fda-grants-lin-bioscience-rare-pediatric-disease-status-for-lbs-008-to-treat-stargardt-disease/2479877/Lin BioScience announced that the FDA has granted rare pediatric disease (RPD) designation to LBS-008, a first-in-class oral therapy for the treatment of Stargardt Disease. The Priority Review Voucher Program is intended to encourage development of therapies to prevent and treat rare pedi
- Heidelberg Engineering OCT Angiography Module Now Available in the United Stateshttps://modernod.com/news/heidelberg-engineering-oct-angiography-module-now-available-in-the-united-states/2479879/Heidelberg Engineering announced that it has received FDA clearance for its OCT Angiography Module (OCTA). The additional module is now available for new and existing Spectralis upgradeable diagnostic imaging devices.